JANX — Janux Therapeutics, Inc. stock price, charts and financials

QT24Janux Therapeutics, Inc.

Janux Therapeutics, Inc. (NASDAQ: JANX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
15.96
+0.64+4.18%
OverviewShort InterestFilings
JANXQT24Janux Therapeutics, Inc.·NASDAQ
15.96+4.18%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 20264Statement of changes in beneficial ownership
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 10, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 20268-KCurrent report
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 294
Page
▼
/ 12